Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00245284 · ClinicalTrials.gov registry record
Predictor of Advanced Subclinical Atherosclerosis
A clinical trial of Coronary Artery Disease, sponsored by PreMD.
- Completed
- Registry status
- 600
- Enrollment target
- 6
- Study locations
NCT00245284: Completed study of Coronary Artery Disease, sponsored by PreMD.
NCT00245284 is a study of Coronary Artery Disease that has completed, run by PreMD. The registered enrollment target is 600 participants, below the 1,284-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (53% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00245284, a study of Coronary Artery Disease, has completed, sponsored by PreMD.
- COMPLETED
- Registry status
- 600 participants
- Enrollment target
- 6
- Study locations
Study Summary
Evaluation of skin cholesterol for cardiovascular risk assessment in asymptomatic individuals at low, intermediate, or high risk based on Framingham Global Risk estimates. Carotid intima-media thickness (IMT), a surrogate marker for atherosclerotic burden, that independently predicts the occurrence of heart attack and stroke, will be the "gold standard" comparator. Hypothesis: Skin cholesterol, as measured by two non-invasive tests, correlates with CAD, as measured by CIMT in this population.
Conditions Studied
Study Locations (6)
Illinois
- Radiant Research - Chicago
- University of Chicago - Chicago
Maryland
- Johns Hopkins Hospital - Baltimore
Minnesota
- University of Minnesota - Minneapolis
Pennsylvania
- University od Pennsylvania - Philadelphia
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2005-09 |
| Est. Completion | 2006-05 |
What the finished NCT00245284 record still lists
NCT00245284 is an observational study that tracks outcomes without assigning an intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, below the 1,284-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (53% lower).
The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00245284 lists 6 locations in 5 states (Illinois, Maryland, Minnesota).
Frequently Asked Questions
What is clinical trial NCT00245284 about?
NCT00245284 is a clinical study titled "Predictor of Advanced Subclinical Atherosclerosis". Evaluation of skin cholesterol for cardiovascular risk assessment in asymptomatic individuals at low, intermediate, or high risk based on Framingham Global Risk estimates. Carotid intima-media thickness (IMT), a surrogate marker for atherosclerotic burden, that independently predicts the occurrence ...
What is the current status of trial NCT00245284?
This trial is currently completed. The enrollment target is 600 participants. The study started on 2005-09. Estimated completion is 2006-05.
What conditions does trial NCT00245284 study?
This clinical trial studies the following conditions: Coronary Artery Disease.
Who is sponsoring clinical trial NCT00245284?
This trial is sponsored by PreMD, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00245284 being conducted?
This trial has 6 study locations across Illinois, Maryland, Minnesota, Pennsylvania, Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Coronary Artery Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00245284's enrollment target sits among peer trials
600 67th of 219 higher than 151 of 219 other Coronary Artery Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation
RECRUITING · NA
-
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
RECRUITING · NA
-
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
RECRUITING · NA
-
Factors Affect Outcomes in Cardiovascular Surgery
RECRUITING
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Change in Cardiovascular Health
RECRUITING · NA
-
Impact of Disclosing Coronary Artery Disease Polygenic Risk Score on Cardiovascular Health
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia